Inventor · disambiguated record
Matthew J. Mcginniss
Also filed as: MCGINNISS MATTHEW J
24 granted patents·25 pending applications·121 citations·filing 2005–2025
96Inventor score
Files withCARIS MPI INC31QUEST DIAGNOSTICS INVEST INC9MCGINNISS MATTHEW J3QUEST DIAGNOSTICS INVEST LLC2SUN WEIMIN2
Top patents by PatentIndex Score
49 records- 0198US9389234B2Molecular profiling of tumorsCARIS MPI INC·Filed 2014·Granted Jul 12, 2016·37 cites·20 claims
- 0297US9292660B2Molecular profiling of tumorsCARIS MPI INC·Filed 2014·Granted Mar 22, 2016·18 cites·24 claims
- 0396US9092392B2Molecular profiling of tumorsCARIS MPI INC·Filed 2014·Granted Jul 28, 2015·11 cites·20 claims
- 0495US9322067B2Molecular profiling of tumorsCARIS MPI INC·Filed 2014·Granted Apr 26, 2016·8 cites·20 claims
- 0595US8768629B2Molecular profiling of tumorsVON HOFF DANIEL D·Filed 2010·Granted Jul 1, 2014·16 cites·48 claims
- 0693US9064045B2Molecular profiling of tumorsCARIS MPI INC·Filed 2014·Granted Jun 23, 2015·6 cites·20 claims
- 0793US9058418B2Molecular profiling of tumorsCARIS MPI INC·Filed 2014·Granted Jun 16, 2015·6 cites·24 claims
- 0893US9053224B2Molecular profiling of tumorsCARIS MPI INC·Filed 2014·Granted Jun 9, 2015·6 cites·23 claims
- 0988US8338578B1Cystic fibrosis gene mutationsMCGINNISS MATTHEW J·Filed 2005·Granted Dec 25, 2012·6 cites·5 claims
- 1082US2020003796A1Molecular profiling of tumorsCARIS MPI INC·Filed 2019·Application pending·0 cites
- 1179US12366585B2Molecular profiling of tumorsCARIS MPI INC·Filed 2022·Granted Jul 22, 2025·0 cites·20 claims
- 1279US11447826B2Cystic fibrosis transmembrane conductance regulator gene mutationsQUEST DIAGNOSTICS INVEST LLC·Filed 2019·Granted Sep 20, 2022·0 cites·5 claims
- 1379US2025251410A1Molecular profiling of tumorsCARIS MPI INC·Filed 2025·Application pending·0 cites
- 1475US2021095344A1Cystic fibrosis gene mutationsQUEST DIAGNOSTICS INVEST LLC·Filed 2020·Application pending·0 cites
- 1574US9410203B2Cystic fibrosis transmembrane conductance regulator gene mutationsQUEST DIAGNOSTICS INVEST INC·Filed 2014·Granted Aug 9, 2016·0 cites·7 claims
- 1674US2017228522A1Molecular profiling of tumorsCARIS MPI INC·Filed 2017·Application pending·0 cites
- 1773US10793910B2Cystic fibrosis gene mutationsQUEST DIAGNOSTICS INVEST INC·Filed 2017·Granted Oct 6, 2020·0 cites·6 claims
- 1873US9228237B2Cystic fibrosis gene mutationsQUEST DIAGNOSTICS INVEST INC·Filed 2013·Granted Jan 5, 2016·0 cites·5 claims
- 1972US10501799B2Cystic fibrosis transmembrane conductance regulator gene mutationsQUEST DIAGNOSTICS INVEST INC·Filed 2018·Granted Dec 10, 2019·0 cites·6 claims
- 2072US8124345B2Cystic fibrosis transmembrane conductance regulator gene mutationsSUN WEIMIN·Filed 2010·Granted Feb 28, 2012·2 cites·26 claims
- 2172US2016232289A1Molecular profiling of tumorsCARIS MPI INC·Filed 2016·Application pending·0 cites
- 2272US2016224742A1Molecular profiling of tumorsCARIS MPI INC·Filed 2016·Application pending·0 cites
- 2372US2016224746A1Molecular profiling of tumorsCARIS MPI INC·Filed 2016·Application pending·0 cites
- 2472US2016224747A1Molecular profiling of tumorsCARIS MPI INC·Filed 2016·Application pending·0 cites
- 2572US2016224728A1Molecular profiling of tumorsCARIS MPI INC·Filed 2016·Application pending·0 cites
- 2672US2017199209A1Molecular profiling of tumorsVON HOFF DANIEL D·Filed 2017·Application pending·0 cites
- 2772US2016232286A1Molecular profiling of tumorsCARIS MPI INC·Filed 2016·Application pending·0 cites
- 2872US2016224745A1Molecular profiling of tumorsCARIS MPI INC·Filed 2016·Application pending·0 cites
- 2972US2016232285A1Molecular profiling of tumorsCARIS MPI INC·Filed 2016·Application pending·0 cites
- 3072US2016224729A1Molecular profiling of tumorsCARIS MPI INC·Filed 2016·Application pending·0 cites
- 3172US2016224726A1Molecular profiling of tumorsCARIS MPI INC·Filed 2016·Application pending·0 cites
- 3272US2016232288A1Molecular profiling of tumorsCARIS MPI INC·Filed 2016·Application pending·0 cites
- 3372US2016304972A1Molecular profiling of tumorsCARIS MPI INC·Filed 2016·Application pending·0 cites
- 3472US2016232283A1Molecular profiling of tumorsCARIS MPI INC·Filed 2016·Application pending·0 cites
- 3572US2016224725A1Molecular profiling of tumorsCARIS MPI INC·Filed 2016·Application pending·0 cites
- 3672US2016224727A1Molecular profiling of tumorsCARIS MPI INC·Filed 2016·Application pending·0 cites
- 3772US2016232287A1Molecular profiling of tumorsCARIS MPI INC·Filed 2016·Application pending·0 cites
- 3872US2016232284A1Molecular profiling of tumorsCARIS MPI INC·Filed 2016·Application pending·0 cites
- 3971US7803548B1Methods for diagnosing cystic fibrosisQUEST DIAGNOSTICS INVEST INC·Filed 2008·Granted Sep 28, 2010·3 cites·13 claims
- 4070US2016054325A1Molecular profiling of tumorsCARIS MPI INC·Filed 2015·Application pending·0 cites
- 4170US2015361508A1Molecular profiling of tumorsCARIS MPI INC·Filed 2015·Application pending·0 cites
- 4269US2016171175A9Molecular profiling of tumorsCARIS MPI INC·Filed 2015·Application pending·0 cites
- 4368US9909183B2Cystic fibrosis transmembrane conductance regulator gene mutationsQUEST DIAGNOSTICS INVEST INC·Filed 2016·Granted Mar 6, 2018·0 cites·7 claims
- 4466US7794937B2Cystic fibrosis transmembrane conductance regulator gene mutationsQUEST DIAGNOSTICS INVEST INC·Filed 2006·Granted Sep 14, 2010·2 cites·38 claims
- 4563US8076078B2Cystic fibrosis gene mutationsMCGINNISS MATTHEW J·Filed 2010·Granted Dec 13, 2011·0 cites·11 claims
- 4657US9840740B2Cystic fibrosis gene mutationsQUEST DIAGNOSTICS INVEST INC·Filed 2015·Granted Dec 12, 2017·0 cites·7 claims
- 4753US8753817B2Cystic fibrosis transmembrane conductance regulator gene mutationsSUN WEIMIN·Filed 2012·Granted Jun 17, 2014·0 cites·26 claims
- 4852US8460871B2Cystic fibrosis gene mutationsMCGINNISS MATTHEW J·Filed 2011·Granted Jun 11, 2013·0 cites·27 claims
- 4951US7820388B2Cystic fibrosis transmembrane conductance regulator gene mutationsQUEST DIAGNOSTICS INVEST INC·Filed 2007·Granted Oct 26, 2010·0 cites·16 claims
Join the waitlist — get patent alerts
Get an alert when Matthew J. Mcginniss files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →